Literature DB >> 1606775

The spectrum of cardiovascular abnormalities in autosomal dominant polycystic kidney disease: a 10-year follow-up in a five-generation kindred.

M Timio1, C Monarca, S Pede, S Gentili, C Verdura, S Lolli.   

Abstract

Clinical, electrocardiographic and echocardiographic data were collected in a group of 228 patients with autosomal dominant polycystic kidney disease (PKD) and in another group of 146 unaffected members (NPKD) both comprised in a five-generation kindred followed for 10 years, in order to determine the profile and prevalence of cardiovascular derangement of the genetic disease. A family of 181 members was used as a control. The prevalence of left ventricular hypertrophy in the three groups was 24, 14 and 6% respectively (p less than 0.01); after 10 years it increased up to 35, 26 and 13% respectively (p less than 0.05). The evidence of mitral-valve prolapse was more frequent in PKD and in NPKD group (25 and 20% respectively) than in control subjects (2%) (p less than 0.0001). Mitral incompetence was found in 30, 18 and 8% of those groups respectively (p less than 0.002). The large difference in mitral involvement did not change over time. Tricuspid valve prolapse was detected in 5, 4 and 1% of the three groups, respectively (p less than 0.05). A small increase in frequency was found after 10 years only in polycystic kidney disease patients. Regurgitant aortic lesions were present in higher prevalence in PKD (19%) and NPKD (17%) members than in controls (5%) (p less than 0.001). After 10 years they were 23, 20 and 8%, respectively.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1992        PMID: 1606775

Source DB:  PubMed          Journal:  Clin Nephrol        ISSN: 0301-0430            Impact factor:   0.975


  12 in total

Review 1.  Nephrology, dialysis and transplantation.

Authors:  K Farrington; P Sweny
Journal:  Postgrad Med J       Date:  1993-07       Impact factor: 2.401

2.  Left ventricular mass in normotensive subjects with autosomal dominant polycystic kidney disease.

Authors:  A K Saggar-Malik; C G Missouris; J S Gill; D R Singer; N D Markandu; G A MacGregor
Journal:  BMJ       Date:  1994-12-17

3.  Coronary artery ectasia in a patient with polycystic kidney disease.

Authors:  Leili Pourafkari; Samad Ghaffari; Bizhan Zamani; Mehdi Tolui
Journal:  J Cardiovasc Thorac Res       Date:  2011-08-20

4.  Prevalence of cardiac valvar abnormalities in children and young people with autosomal dominant polycystic kidney disease.

Authors:  Alexandra Savis; John M Simpson; Saleha Kabir; Kelly Peacock; Hayley Beardsley; Manish D Sinha
Journal:  Pediatr Nephrol       Date:  2022-06-28       Impact factor: 3.714

5.  Echocardiographic Findings and Genotypes in Autosomal Dominant Polycystic Kidney Disease.

Authors:  Ryohei Miyamoto; Akinari Sekine; Takuya Fujimaru; Tatsuya Suwabe; Hiroki Mizuno; Eiko Hasegawa; Masayuki Yamanouchi; Motoko Chiga; Takayasu Mori; Eisei Sohara; Shinichi Uchida; Naoki Sawa; Yoshifumi Ubara; Junichi Hoshino
Journal:  Kidney Dis (Basel)       Date:  2021-11-26

Review 6.  Cardiovascular abnormalities in autosomal-dominant polycystic kidney disease.

Authors:  Tevfik Ecder; Robert W Schrier
Journal:  Nat Rev Nephrol       Date:  2009-04       Impact factor: 28.314

7.  ADPKD: Prototype of Cardiorenal Syndrome Type 4.

Authors:  Grazia Maria Virzì; Valentina Corradi; Anthi Panagiotou; Fiorella Gastaldon; Dinna N Cruz; Massimo de Cal; Maurizio Clementi; Claudio Ronco
Journal:  Int J Nephrol       Date:  2010-12-21

8.  Developments in the management of autosomal dominant polycystic kidney disease.

Authors:  Amirali Masoumi; Berenice Reed-Gitomer; Catherine Kelleher; Mir Reza Bekheirnia; Robert W Schrier
Journal:  Ther Clin Risk Manag       Date:  2008-04       Impact factor: 2.423

Review 9.  Polycystic liver disease: an overview of pathogenesis, clinical manifestations and management.

Authors:  Wybrich R Cnossen; Joost P H Drenth
Journal:  Orphanet J Rare Dis       Date:  2014-05-01       Impact factor: 4.123

10.  Clinical presentation and outcome of autosomal dominant polycystic kidney disease in Nigeria.

Authors:  Fatiu A Arogundade; Akinwumi A Akinbodewa; Abefe A Sanusi; Oluyomi Okunola; Muzamil O Hassan; Adewale Akinsola
Journal:  Afr Health Sci       Date:  2018-09       Impact factor: 0.927

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.